This story was originally posted on April 27.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cronus Technologies has inked a distribution deal with PamGene International covering the UK and Ireland.
The Dutch array vendor is working closely with partners in the pharmaceutical industry and academia to optimize internally developed kinase-screening assays for use in drug discovery and as companion diagnostics.
Kinexus President Steven Pelech told BioArray News recently that the new kinase-inhibitor screening service will complement the firm's menu of Kinex antibody and reverse lysate microarrays.
Microarray-related Papers of Note Published in June 2009
The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.
The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.
The first Reproducibility Project: Cancer Biology papers show mixed results.
In Nature this week: mobile phone-based targeted DNA sequencing, and more.